Sumit Punj

1.6k total citations
16 papers, 248 citations indexed

About

Sumit Punj is a scholar working on Genetics, Molecular Biology and Nephrology. According to data from OpenAlex, Sumit Punj has authored 16 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 4 papers in Nephrology. Recurrent topics in Sumit Punj's work include Renal and related cancers (4 papers), Renal Diseases and Glomerulopathies (4 papers) and T-cell and B-cell Immunology (4 papers). Sumit Punj is often cited by papers focused on Renal and related cancers (4 papers), Renal Diseases and Glomerulopathies (4 papers) and T-cell and B-cell Immunology (4 papers). Sumit Punj collaborates with scholars based in United States, Poland and Germany. Sumit Punj's co-authors include Nancy I. Kerkvliet, Siva K. Kolluri, Jamie M. Pennington, Diana Rohlman, Edmond F. O’Donnell, Hyo Sang Jang, Prasad Kopparapu, Allison Ehrlich, Xisheng Wang and Daniel C. Koch and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Sumit Punj

14 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumit Punj United States 9 97 67 60 50 37 16 248
Mandeep Takhar Canada 9 159 1.6× 29 0.4× 16 0.3× 28 0.6× 11 0.3× 13 320
Ruth D. Coldwell United Kingdom 13 55 0.6× 27 0.4× 31 0.5× 28 0.6× 27 0.7× 18 325
Ye Kang China 11 202 2.1× 19 0.3× 32 0.5× 9 0.2× 44 1.2× 23 347
Claudia Einer Germany 5 68 0.7× 7 0.1× 17 0.3× 24 0.5× 11 0.3× 6 163
Neil J. Schroeder United Kingdom 10 48 0.5× 61 0.9× 7 0.1× 7 0.1× 88 2.4× 20 337
Daisuke Yamamuro Japan 11 116 1.2× 11 0.2× 61 1.0× 6 0.1× 5 0.1× 18 322
Theresa Maria Holtmann Germany 5 130 1.3× 10 0.1× 43 0.7× 4 0.1× 15 0.4× 10 321
Xuanming Pan China 6 246 2.5× 24 0.4× 60 1.0× 5 0.1× 5 0.1× 7 362
Lesley-Ann Huggins United States 7 98 1.0× 17 0.3× 45 0.8× 6 0.1× 18 0.5× 7 299
Naoshi Horiba Japan 10 72 0.7× 59 0.9× 10 0.2× 10 0.2× 145 3.9× 20 264

Countries citing papers authored by Sumit Punj

Since Specialization
Citations

This map shows the geographic impact of Sumit Punj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumit Punj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumit Punj more than expected).

Fields of papers citing papers by Sumit Punj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumit Punj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumit Punj. The network helps show where Sumit Punj may publish in the future.

Co-authorship network of co-authors of Sumit Punj

This figure shows the co-authorship network connecting the top 25 collaborators of Sumit Punj. A scholar is included among the top collaborators of Sumit Punj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumit Punj. Sumit Punj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Stein, Quinn, et al.. (2025). Role of Comprehensive Renal Genetic Testing in Diagnosing a RMND‐1 Mitochondrial Disease in Two Adult Cases Exhibiting Variable Disease Phenotypes. Clinical Case Reports. 13(4). e70421–e70421. 1 indexed citations
2.
Stein, Quinn, et al.. (2025). P687: A master in mimicry: Expanding the renal phenotype of COL4A1-related disorders. Genetics in Medicine Open. 3. 103056–103056.
3.
Francisco, Ronaldo da Silva, Sumit Punj, Lisa M. Vincent, et al.. (2024). Prevalence of Mendelian Kidney Disease Among Patients With High-Risk APOL1 Genotypes Undergoing Commercial Genetic Testing in the United States. Kidney International Reports. 9(9). 2667–2676. 1 indexed citations
4.
Stein, Quinn, et al.. (2024). Townes-Brocks Syndrome Revealed by Kidney Gene Panel Testing. Kidney International Reports. 9(6). 1810–1816. 3 indexed citations
5.
Clark, Dinah, Robert Burns, Michelle S. Bloom, et al.. (2024). Heterozygous loss of function variants in IFT140 are associated with polycystic kidney disease. American Journal of Medical Genetics Part A. 194(12). e63841–e63841.
6.
Dahl, Neera K., Michelle S. Bloom, Fouad T. Chebib, et al.. (2023). The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease. Journal of the American Society of Nephrology. 34(12). 2039–2050. 29 indexed citations
7.
Stein, Quinn, et al.. (2023). Isolated benign persistent proteinuria with novel association of CUBN (cubilin) variants. SHILAP Revista de lepidopterología. 11(6). e7502–e7502. 2 indexed citations
8.
Bleyer, Anthony J., Jing Xie, Michelle S. Bloom, et al.. (2022). Genetic Etiologies for Chronic Kidney Disease Revealed through Next-Generation Renal Gene Panel. American Journal of Nephrology. 53(4). 297–306. 28 indexed citations
9.
Hauser, Natalie, Sumit Punj, Katrina Prescott, et al.. (2020). Mosaicism in ASXL3-related syndrome: Description of five patients from three families. European Journal of Medical Genetics. 63(6). 103925–103925. 9 indexed citations
10.
Rope, Alan F., Tia L. Kauffman, Laura M. Amendola, et al.. (2018). A case for expanding carrier testing to include actionable X‐linked disorders. Clinical Case Reports. 6(11). 2092–2095. 2 indexed citations
11.
Wilfond, Benjamin S., Tia L. Kauffman, Gail P. Jarvik, et al.. (2018). Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision Making. Health Affairs. 37(5). 809–816. 9 indexed citations
12.
Ehrlich, Allison, Jamie M. Pennington, Susan C. Tilton, et al.. (2017). AhR activation increases IL‐2 production by alloreactive CD4+T cells initiating the differentiation of mucosal‐homing Tim3+Lag3+Tr1 cells. European Journal of Immunology. 47(11). 1989–2001. 29 indexed citations
13.
Koch, Daniel C., Hyo Sang Jang, Edmond F. O’Donnell, et al.. (2015). Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1. Oncogene. 34(50). 6092–6104. 41 indexed citations
14.
Ehrlich, Allison, Jamie M. Pennington, Xisheng Wang, et al.. (2015). Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice. The Journal of Immunology. 196(1). 264–273. 43 indexed citations
15.
Punj, Sumit, Prasad Kopparapu, Hyo Sang Jang, et al.. (2014). Benzimidazoisoquinolines: A New Class of Rapidly Metabolized Aryl Hydrocarbon Receptor (AhR) Ligands that Induce AhR-Dependent Tregs and Prevent Murine Graft-Versus-Host Disease. PLoS ONE. 9(2). e88726–e88726. 39 indexed citations
16.
Rohlman, Diana, et al.. (2013). Suppression of Acute Graft-Versus-Host Response by TCDD Is Independent of the CTLA-4-IFN-γ-IDO pathway. Toxicological Sciences. 135(1). 81–90. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026